A cardiologist has issued a warning about the potential risks associated with stopping weight loss injections, following new research published in The Lancet Regional Health - Europe. The study, which analyzed the medical records of over 80,000 individuals with type 2 diabetes across 301 clinics in Italy, found that those who discontinued GLP-1 medication had a higher risk of heart attack, stroke, and death. The combined rate of these events was approximately twice as high among those who stopped treatment. Dr. Francesco Lo Monaco, cardiologist and founder of the National Longevity Clinic, emphasized the importance of understanding the potential cardiovascular consequences of discontinuing treatment. The study did not prove that stopping the medication directly caused the higher risk, but it did highlight the need for careful consideration before discontinuing treatment. Dr. Lo Monaco advised that individuals should not stop prescribed medication without consulting their healthcare professional first. The research also noted that further investigations are required to establish whether discontinuing GLP-1 treatment directly impacts cardiovascular risk. #WeightLoss #CardiovascularHealth #GLP1Medication #Diabetes #HealthWarning
También lo cubren: walesonline.co.uk - WalesOnline - Home (Reino Unido).
🔗 Leer la noticia completa en walesonline.co.uk - WalesOnline - Home
Ver más en NewsToday